Connect with us

News

Breakthrough as New Vaccine Clears HIV Virus in Monkeys

Published

on

HIV.jpg
Kindly share this post

Global science has finally confirmed cure for Human Immune Virus (HIV), one of the world killer diseases as new studies have proved a vaccine for the monkey equivalent of HIV can eradicate the virus.

The latest report further explained that the new vaccine which cures simian immunodeficiency virus (SIV), an infection found in monkeys similar to HIV, would ultimately help scientists create a human version for HIV.

 In recent years, spates of findings have shown that HIV can essentially be eradicated in some patients.

Since then, scientists have been scrambling to ultimately find a cure that could drastically change the lives of millions of people worldwide.

Since the beginning of the epidemic, almost 70 million people have been infected with the HIV virus and about 35 million people have died of AIDS.

Globally, 34.0 million people were living with HIV at the end of 2011. Sub-Saharan Africa remains most severely affected, with nearly one in every 20 adults (4.9 per cent) living with HIV and accounting for 69 per cent of the people living with HIV worldwide.

In Nigeria, it is estimated that 3.4 million persons live with the virus.

According to the study from the Vaccine and Gene Therapy Institute at Oregon Health and Science University, published in the journal Nature, researchers tested the vaccine on 16 monkeys infected with an aggressive form of SIV called SIVmac239.

Nine of the 16 monkeys had the infection completely eliminated from their bodies.

These monkeys were still infection-free between one-and-a-half to three years later. Further research is needed to determine why the vaccine only worked on some monkeys. Researchers also hope to test how the vaccine affects monkeys already infected with SIV, and eventually, if the vaccine could work in humans.

A potential HIV vaccine is still years away. But recent research has developed two vaccines for other infectious diseases that could be available sooner.

Acquired Immune Deficiency Syndrome (AIDS) was first recognized as a new disease in 1981 when increasing numbers of young homosexual men succumbed to unusual opportunistic infections and rare malignancies.

A retrovirus, now termed human immunodeficiency virus type 1 (HIV-1), was subsequently identified as the causative agent of what has since become one of the most devastating infectious diseases to have emerged in recent history.

HIV-1 spreads by sexual, percutaneous, and perinatal routes, however, 80 per cent of adults acquire HIV-1 following exposure at mucosal surfaces, and AIDS is thus primarily a sexually transmitted disease.

But based on the latest discovery, the authors said that they will adopt similar approach adopted for the monkeys to test a vaccine for HIV in humans. Commenting, Prof Louis Picker, from the Vaccine and Gene Therapy Institute at Oregon Health and Science University, said: “It is always tough to claim eradication – there could always be a cell which we didn’t analyse that has the virus in it.

But for the most part, with very stringent criteria… there was no virus left in the body of these monkeys.”

The research team looked at an aggressive form of virus called SIVmac239, which is up to 100 times more deadly than HIV. Infected monkeys usually die within two years, but in some inoculated primates, the virus did not take hold.

The vaccine is based on another virus called cytomegalovirus (CMV), which belongs to the herpes family.

It used the infectious power of CMV to sweep throughout the body. But instead of causing disease, it has been modified to spur the immune system into action to fight off the SIV molecules.

“It maintains an armed force, that patrols all the tissues of the body, all the time, indefinitely,” explained Prof Picker. The researchers gave rhesus macaque monkeys the vaccine, and then exposed them to SIV.

They found that at first, the infection began to establish and spread. But then the monkeys’ bodies started to respond, searching out and destroying all signs of the virus.

Of the monkeys that successfully responded to the vaccine, they were still clear of infection between one-and-a-half and three years later.

Prof Picker said his team was still trying to work out why the vaccination worked in only about half of the monkeys. “It could be the fact that SIV is so pathogenic that this is the best you are ever going to get.

There is a battle going on, and half the time the vaccine wins and half the time it does not,” he said. The researchers are now testing the vaccine to see if it can be used after SIV exposure to treat and potentially cure infected monkeys. They also want to see if the technique could work in humans.

Prof Picker said: “In order to make a human version, we have to make sure it is absolutely safe. We have now engineered a CMV virus which generates the same immune response, but has been attenuated (modified to lose its virulence) to the point where we think it is unequivocally safe.”

 This would first have to pass through the regulatory authorities, but if it does, he said he hoped to start the first clinical trials in humans in the next two years.

Commenting on the research, Dr Andrew Freedman, from Cardiff University School of Medicine, said: “This suggests that prophylactic vaccines – vaccines designed to prevent infection – using CMV vectors may be a promising approach for HIV. While they may not prevent the initial infection, they might lead to subsequent clearance, rather than the establishment of chronic infection.”


Kindly share this post

Dear Reader, Your support matters. But we believe that technology makes life more exciting and helps improve the lives of people around Nigeria and indeed the world. That is why, we have devoted our energy to independent reportage of technology and finance and how they affect lives. Our incisive and analytical view of how technology news affects the daily life help individuals and organizations make up their minds. Quality journalism costs money. Today, we're asking that you support us to do more. Kindly support our effort to deliver technology and finance journalism to everyone in the world. Donate as little as N1,000. Bank transfers can be made to: UBA Plc 1017156876 Communication Week Media Ltd

Continue Reading
Advertisement
Comments

News

‘Fraudsters Have Cloned my Voice’- Akume

Published

on

Kindly share this post

George Akume, secretary to the Government of the Federation, has raised alarm over the activities of a criminal syndicate allegedly cloning his voice and using it to defraud unsuspecting Nigerians with promises of Federal Government appointments.

‘Fraudsters Have Cloned my Voice’ – Akume

George Akume, SGF

In a statement issued by Yomi Odunuga, his special adviser on Media and Publicity, on Thursday, Akume said the fraudsters have impersonated him in audio calls and text messages, targeting high-profile individuals and soliciting payments ranging from ₦5 million to ₦15 million in exchange for phantom political positions.

“From information available to the office, the fraudsters cloned the voice of the SGF, using it to solicit money in return for federal appointments,” the statement read.

The SGF further revealed that the scammers not only cloned his voice but also spoofed the phone numbers of other high-profile individuals to give credibility to their fraudulent scheme.

“These scammers attach bank account details to messages sent to victims and request them to send their CVs to cloned emails,” Odunuga added.

The statement noted that the fraudsters have been operating through both traditional bank accounts and fintech mobile wallets, complicating efforts to trace the financial trails.

Distancing himself from the illicit scheme, Akume stressed that appointments to Federal Government boards and parastatals are transparent and not for sale under any guise.

The statement noted, “Senator Akume emphasized that the appointment processes for Nigerians into boards and parastatals are transparent and verifiable, urging individuals not to pay any money in expectation of securing a position.”

The Office of the SGF confirmed that it has notified relevant security agencies, urging members of the public to report suspicious calls or messages to law enforcement.

“The Office of the SGF strongly advises Nigerians to report the activities of these fraudulent people to the authorities while taking all precautionary steps necessary to avoid being victims of th


Kindly share this post
Continue Reading

News

Olukoyede, EFCC Chair Denies Forcing Ojulari to Resign as NNPC Boss

Published

on

Kindly share this post

Ola Olukoyede, executive chairman, Economic and Financial Crimes Commission (EFCC),  has denied claims that he compelled Bayo Ojulari, group chief executive officer, Nigerian National Petroleum Company Limited (NNPCL), to step down from his role.

Olukoyede, EFCC Chair Denies Forcing Ojulari to Resign as NNPC Boss

Bayo Ojulari,

The allegations stemmed from an August 2, 2025, online publication which alleged that Olukoyede and Adeola Ajayi, director general, Department of State Services (DSS),  pressured Ojulari into signing a resignation letter during a closed-door meeting in Abuja.

The report also suggested that Ojulari was interrogated over his purported links to Olatimbo Ayinde, British-Nigerian oil mogul, who is reportedly close to key figures in the present administration.

In a follow-up story, the news outlet further claimed Ojulari was later invited to the Presidential Villa, where First Lady Senator Remi Tinubu reportedly opposed his resignation.

Responding to the allegations, Dele Oyewale, spokesman, EFCC<  issued a statement on Wednesday on behalf of the Commission, noting that Olukoyede, through his legal counsel Adeyinka Olumide-Fusika (SAN), described the publications as defamatory and injurious to his integrity.

“The publications and the imputations conveyed by them are so damning and cannot be ignored or treated with levity,” the statement quoted.

Olukoyede denied any suggestion that he was acting at the behest of Ayinde or that his actions were influenced by external political figures.

A letter addressed to the editor of the publication, signed by Olumide-Fusika, reiterated the gravity of the claims and insisted on corrective measures.

“He, therefore, demanded that the medium acknowledge your wrongdoing, expressly admit that what you published and imputed against my client are false, apologise for it unreservedly and retract and pull down the stories from your newspaper website and social media handles,” the statement added.

Olukoyede said the story portrayed him as “someone that has betrayed and subverted public trust by submitting the authority of his public office and trust as Chairman of the EFCC to the dictates and directives of one Olatimbo Ayinde.”

Labelling the report as entirely fabricated, Olukoyede demanded an official apology and complete removal of the story from the outlet’s digital platforms within 48 hours.

 

 

 


Kindly share this post
Continue Reading

News

PalmPay Partners FG to Drive Data Protection Awareness

Published

on

Kindly share this post

PalmPay reinforced its commitment to data protection and youth empowerment with a ground-breaking partnership with the Federal Ministry of Youth Development to launch the Youth Data Protection Awareness and Training (YDPAT) Program, which is targeted at equipping over 1,000,000 Nigerian youths digitally over 3 years.

The training program, commissioned last week at the Shehu Musa Yar’ Adua Centre in Abuja, will focus on providing youths with the right knowledge and skills required to navigate the digital landscape safely. With over 70% of the Nigerian population consisting of youths, this is an important move to foster trust, security and youth-focused innovation.

Speaking at the launch, the Honourable Minister of Youth Development, Comrade Ayodele Olawande, commended PalmPay’s partnership in the actualisation of the program and described YDPAT as a bold step toward building a digitally literate and security-conscious generation.

In his words, “This is about building a privacy-first generation, one that is inclusive, future-facing, and globally competitive.” He also emphasised the low awareness of the Nigerian Data Protection Act (NDPA), 2023 and the critical shortage of certified Data Protection Officers (DPOs), despite over 500,000 data controllers operating in the country.

This position was equally supported by PalmPay’s Managing Director, Mr Chika Nwosu, who stated how data protection is as important as innovation in tech. He noted that PalmPay integrates privacy into every stage of its product development, ensuring that user information is safe.

Beyond ensuring data protection, PalmPay is committed to empowering young Nigerians with real opportunities for growth, with mentorship and internship placements for top-performing participants. It has led several youth-oriented initiatives, including the Purple Woman campaign, and Passing the Baton CSR for thousands of youths and women in urban and rural communities.

With a drive to achieve nationwide digital literacy, PalmPay is championing campaigns in Northern Nigeria, with more activations planned across various states.

 


Kindly share this post
Continue Reading

Trending